Progress of respiratory syncytial virus vaccine / 国际儿科学杂志
International Journal of Pediatrics
;
(6): 267-270, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-692487
ABSTRACT
Respiratory syncytial virus(RSV) infection is an important factor for causing illness and death in global high-risk groups,such as infants,children,and immunocompromised patients,and the elderly.As a high risk factor,there is still no safe and effective vaccine.Therefore,RSV vaccine has been regarded as one of the vaccines that needs to be developed globally by the World Health Organization(WHO).The important biological characteristics such as the structure of RSV,infection mechanism,and two important glycoproteinsfusion and attachment,active and passive immunization vaccine development,as well as some of the aspects were reviewed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Factores de riesgo
Idioma:
Chino
Revista:
International Journal of Pediatrics
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS